NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

PulseSelect™ PFA Global Registry

RecruitingN/A

Sponsor: Medtronic Cardiac Ablation Solutions

Conditions: Atrial Fibrillation

Countries: Belgium, Canada, China, Croatia, France, Germany, Greece, Italy

The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Subject is ≥ 18 years of age or minimum age as required by local regulations.
* Subject has been diagnosed with atrial fibrillation (AF)
* Planned procedure using commercially available PulseSelect™ PFA System.
* Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements.

Exclusion Criteria:

* Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager.
* Subject with exclusion criteria required by local law.

Locations (43)

Hasselt, Belgium
Vancouver, British Columbia, Canada
Montreal, Quebec, Canada
Beijing, China
Fuzhou, China
Harbin, China
Kunming, China
Nanjing, China
Shanghai, China
Shenzhen, China
Ürümqi, China
Wuhan, China
Xiamen, China
Zhengzhou, China
Zagreb, Croatia
Zagreb, Croatia
Grenoble, France
Le Coudray, France
Massy, France
Paris, France
Toulouse, France
Frankfurt, Germany
Heidelberg, Germany
Ludwigshafen am Rhein, Germany
Paderborn, Germany
Paderborn, Germany
Athens, Greece
Negrar, Verona, Italy
Ancona, Italy
Nieuwegein, Netherlands
+ 13 more on CT.gov